Drug Discovery AI
Drug Discovery AI
Agent21Agent Readiness: 21/100. Bottom 25%. Measured by StartupHub.ai. Median 41.AI platform accelerating the discovery of novel therapeutics.
About
Valence Labs is Recursion's AI research engine, focused on predicting, explaining, and discovering new ways to decode biology. It leverages Recursion's platform, data, and computing infrastructure to model cellular responses to perturbations, generate causal explanations for molecular interventions, and discover novel therapeutic hypotheses. Valence Labs serves the drug discovery industry by accelerating and improving therapeutic outcomes.
Key facts
At-a-glance profile data
- Website
- valencelabs.com
- Headquarters
- Boston, United States
- Founded
- 2023
- Employees
- 35
- Total funding
- -
- Business model
- B2B
Tech stack
Detected on valencelabs.com, last scanned 21 Aug 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Google Workspace
- Email marketing
- Substack
Add first review
Frequently asked
How many employees does Drug Discovery AI have?
Drug Discovery AI has approximately 35 people on record.